Core Concept
Importance of new drug development based on clinically relevant biomarkers
![Importance of new drug development based on clinically relevant biomarkers](/wp-content/uploads/rnd1_con1_img_en.jpg)
![Importance of new drug development based on clinically relevant biomarkers](/wp-content/uploads/rnd1_con1_img_m_en.jpg)
Core Technology
CTA (Clinical-based Target for Antibody Drug) Platform for Efficient Drug Development
CTA Platform
![서울아산병원x울산대학교 의과대학](/wp-content/uploads/rnd1_con1_logo_en.png)
Innovative R&D through precise assessment of target indication
-
C Clinical Unmet Need Based
New Drug DevelopmentClinically Needed Drug
- Pharmaceuticals Needed in Clinic
- Preemptive Clinical Trial Design
- Animal Studies that Mimic Clinical Trials
-
T Target Analysis Based
on Clinical DiseasesTherapeutic Target Selection
- Target Discovery from Patient Tissues
- Disease-Specific Target Analysis
- Target Identification through Drug Responsiveness Prediction
-
A Antibody Development
Antibody therapeutics
- High Affinity & Selectivity for the Target
- High Potency & Productivity
- Monoclonal, Bispecific antibodies, ADCs
![화살표](/wp-content/uploads/rnd1_arrow.png)
![화살표](/wp-content/uploads/rnd1_arrow.png)
![화살표](/wp-content/uploads/rnd1_arrow.png)
-
Biomarker-based diagnostics and therapeutics
-
Animal Studies that Mimic Clinical Trials
-
Clinical Trial monitoring biomarker changes
![화살표](/wp-content/uploads/rnd1_arrow.png)
![화살표](/wp-content/uploads/rnd1_arrow.png)
![화살표](/wp-content/uploads/rnd1_arrow.png)
![화살표](/wp-content/uploads/rnd1_arrow.png)
Innovation
- Market-Leading New Drug
- Pipeline reinforcement
- Global Competitiveness
- Sustainable Growth
![NICE신용평가](/wp-content/uploads/rnd1_con3_logo1_en.png)
Top-tier rating in technology credit assessment
![TI-2 level](/wp-content/uploads/rnd1_con3_img1_en_v2.png)
![중소벤처기업부](/wp-content/uploads/rnd1_con3_logo2_en.png)
Selection as a baby unicorn company
![아기유니콘](/wp-content/uploads/rnd1_con3_img2_en.png)